PL93908B1 - - Google Patents

Download PDF

Info

Publication number
PL93908B1
PL93908B1 PL1974175331A PL17533174A PL93908B1 PL 93908 B1 PL93908 B1 PL 93908B1 PL 1974175331 A PL1974175331 A PL 1974175331A PL 17533174 A PL17533174 A PL 17533174A PL 93908 B1 PL93908 B1 PL 93908B1
Authority
PL
Poland
Prior art keywords
dimethyl
dibenzo
hexahydro
trans
pyran
Prior art date
Application number
PL1974175331A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL93908B1 publication Critical patent/PL93908B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
PL1974175331A 1973-11-05 1974-11-04 PL93908B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (1)

Publication Number Publication Date
PL93908B1 true PL93908B1 (enExample) 1977-07-30

Family

ID=23635420

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1974175331A PL93908B1 (enExample) 1973-11-05 1974-11-04
PL1974191069A PL95748B1 (pl) 1973-11-05 1974-11-04 Sposob wytwarzania nowych szesciowodorodwubenzo-/b,d/piranow

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1974191069A PL95748B1 (pl) 1973-11-05 1974-11-04 Sposob wytwarzania nowych szesciowodorodwubenzo-/b,d/piranow

Country Status (26)

Country Link
US (1) US3968125A (enExample)
JP (1) JPS6033835B2 (enExample)
AR (1) AR202318A1 (enExample)
AT (1) AT336012B (enExample)
BE (1) BE821716A (enExample)
BG (1) BG26387A3 (enExample)
CA (1) CA1023753A (enExample)
CH (1) CH605894A5 (enExample)
CS (1) CS193507B2 (enExample)
DD (1) DD116230A5 (enExample)
DE (1) DE2451934C2 (enExample)
DK (1) DK136719B (enExample)
ES (1) ES431674A1 (enExample)
FR (1) FR2249664B1 (enExample)
GB (1) GB1487637A (enExample)
HU (1) HU169193B (enExample)
IE (1) IE40023B1 (enExample)
IL (1) IL45644A (enExample)
NL (1) NL7414439A (enExample)
PH (1) PH11788A (enExample)
PL (2) PL93908B1 (enExample)
RO (1) RO71766A (enExample)
SE (1) SE415762B (enExample)
SU (1) SU524517A3 (enExample)
YU (1) YU36515B (enExample)
ZA (1) ZA745751B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (enExample) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
US20050101590A1 (en) 2002-02-19 2005-05-12 Kiyoshi Yasui Antipruritics
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
EP2254601B1 (en) 2008-02-08 2019-05-29 Nektar Therapeutics Oligomer-cannabinoid conjugates
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
CN110075069A (zh) 2009-05-06 2019-08-02 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其应用
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2019016814A1 (en) 2017-07-20 2019-01-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. PHARMACEUTICAL FILM COMPOSITIONS FOR THE ADMINISTRATION OF LIPOPHILIC COMPOUNDS IN AND / OR THROUGH THE SKIN
CN111278425B (zh) 2017-09-11 2024-06-11 耶路撒冷希伯来大学伊萨姆研究开发有限公司 用于向脑部经鼻给药药物和用于全身作用的组合物和方法
CA3116187A1 (en) 2017-11-29 2019-06-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabinoids compositions and methods
EP3873436A1 (en) 2018-11-04 2021-09-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
YU265874A (en) 1982-02-25
JPS5071678A (enExample) 1975-06-13
IL45644A (en) 1978-03-10
ZA745751B (en) 1976-04-28
HU169193B (enExample) 1976-10-28
US3968125A (en) 1976-07-06
SE415762B (sv) 1980-10-27
PL95748B1 (pl) 1977-11-30
IL45644A0 (en) 1974-11-29
ATA886374A (de) 1976-08-15
IE40023B1 (en) 1979-02-28
DE2451934C2 (de) 1983-10-06
ES431674A1 (es) 1976-11-16
CH605894A5 (enExample) 1978-10-13
BE821716A (fr) 1975-04-30
SE7413833L (enExample) 1975-05-06
AR202318A1 (es) 1975-05-30
JPS6033835B2 (ja) 1985-08-05
DD116230A5 (enExample) 1975-11-12
DK573274A (enExample) 1975-07-07
DK136719B (da) 1977-11-14
AT336012B (de) 1977-04-12
AU7321274A (en) 1976-03-18
NL7414439A (nl) 1975-05-07
RO71766A (ro) 1982-12-06
SU524517A3 (ru) 1976-08-05
FR2249664B1 (enExample) 1978-03-24
CS193507B2 (en) 1979-10-31
DE2451934A1 (de) 1975-05-07
YU36515B (en) 1984-02-29
GB1487637A (en) 1977-10-05
CA1023753A (en) 1978-01-03
FR2249664A1 (enExample) 1975-05-30
BG26387A3 (bg) 1979-03-15
PH11788A (en) 1978-07-05
IE40023L (en) 1975-05-05
DK136719C (enExample) 1978-04-24

Similar Documents

Publication Publication Date Title
PL93908B1 (enExample)
US4087545A (en) Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
US3928598A (en) Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
Kongkathip et al. Potent antitumor activity of synthetic 1, 2-naphthoquinones and 1, 4-naphthoquinones
US3953603A (en) Hexahydro-dibenzo[b,d,]pyran-9-ones as psychotropic, particularly anti-depressant drugs
Burstein et al. Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities
Suebsasana et al. Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals
US3944673A (en) Hexahydro-dibenzo[b,d]pyran-9-ones as analgesic drugs
Jasim et al. New fused-coumarin composites: Synthesis, anticancer and antioxidant potentials evaluation
JP3278159B2 (ja) (3r,4r)−δ▲上6▼−テトラヒドロカンナビノール−7−酸
CN107405327B (zh) 大麻素化合物的混合物、其制备和应用
US4087546A (en) Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087547A (en) Hexahydro-dibenzo[b,d]pyran-9-ones in treatment of glaucoma
US4088777A (en) Hexahydro-dibenzo[b,d]pyran-9-ones as anticonvulsant drugs
US4278603A (en) Novel polymorphic crystalline form of dibenzopyranone
WO2009024103A2 (en) Natural brassinosteroids for use for treating hyperproliferation, treating proliferative diseases and reducing adverse effects of steroid dysfunction in mammals, pharmaceutical composition and its use
PL105486B1 (pl) Sposob wytwarzania nowych estrowych pochodnych tiazolinylo i tiazynylobenzimidazolu o dzialaniu przeciwwirusowym
US4315862A (en) Process for preparing cannabichromene
IL34238A (en) Morpholinyl ethers and process for their preparation
KR20010070381A (ko) 나프토퀴논계 화합물을 포함하는 항암제
US3987188A (en) Hexahydro-dibenzo[b,d]pyran-9-ones as sedative drugs
JPH08502269A (ja) 新規ベンゾピラノン、それらの製造方法およびそれらの使用
CN103242337B (zh) 一种基于paf/ros双靶点的银杏内酯b衍生物及其制备方法
US4024275A (en) Method of reducing elevated blood pressure with dihydroxy-hexahydrodibenzo(b,d)pyrans
GB1584169A (en) Process for the preparation of 6a,10a-trans-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo-(b,d) pyran-9-ones